Gower Bob G bought 400,000 shares of Ensysce Biosciences, Inc. at $0.50 for $198k on Aug 7, 2026

Buy
Form 4 code P. Open-market or private purchase of a non-derivative or derivative security.
Director
DIR
Filed Aug 18, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$198,000Shares × reported price
Shares traded
400,000Common Stock
Price per share
$0.50Reported price. Read footnotes for ranges.
% of reported position traded
77.41%This security and ownership context
Holdings after
916,740Direct
Trade date
Aug 7, 2026Buy
Filed
Aug 18, 2026, 6:06 AM ET11-day reporting delay
Accession
0001493152-26-038866Code P · Transaction 1531
How reported position traded is calculated

Shares purchased ÷ (holdings after − shares purchased). Estimated position before: 516,740 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Apr 23, 2026Buy508,614$0.48$246,169.18Trade 1530
Apr 23, 2026Conversion254,307——Trade 1532
3 transaction rows in this filing. Joint filers share the same rows.

Filing warnings

Notes recorded with this filing
1 warning
delayed filingThe filing was reported 11 calendar days after the transaction date.

ENSC price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
ENSC · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −29%1w ago −34%1d ago +37%
Returns since7d −2.6%30d +16%90d180d1y

Footnotes in full

F1: The total of securities reported as beneficially owned reflects two reverse stock splits effected by the Issuer subsequent to the last filing on Form 4 by the Reporting Person. F2: Amendment and conversion, without payment of additional consideration, of two senior convertible promissory notes, aggregate principal amount $216,000, issued in 2023 into 254,307 shares of common stock as reported in Table 1 above and a warrant to purchase 254,307 shares of common stock as reported in Table II above. In April 2026, the outstanding principal amount, together with accrued and unpaid interest, was $246,169.